Nominations for the 2010 Award are now closed.
The 2010 Award recipient will be announced in January 2010.
Learn more about the recipient of the 2009 Award. View the list of all prior Award recipients.
The Award and Lecture
AACR and Eli Lilly and Company established this Award in 1961 to honor Dr. G.H.A. Clowes, who was a founding member of the AACR and a research director of Eli Lilly. The Clowes Award recognizes an individual with outstanding recent accomplishments in basic cancer research.
The winner of the 50th Annual AACR G.H.A. Clowes Memorial Award will receive a $10,000 honorarium, give a 50-minute lecture during the AACR 101st Annual Meeting 2010 in Washington, DC, U.S.A. (April 17-21, 2010), and be given support for the winner and a guest to attend the Annual Meeting. The winner will also speak at the Eli Lilly and Company headquarters in Indianapolis, Indiana, at the invitation of the company later in 2010.
Eligibility
- Candidacy is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry, or government.
- The Award will be presented to an individual investigator.
- Institutions or organizations are not eligible for the Award.
Nomination Process
Nominations for the 2011 Award opens Fall 2010.
Nominations may be made by any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Candidates may not nominate themselves.
The following materials must be submitted:
Nomination Letter, which must:
- be addressed to the Selection Committee; be written in English; and not exceed 1,000 words;
- specify the AACR Award for which the candidate is being nominated;
- a concise description of the candidate's outstanding recent accomplishments in basic cancer research, with the publications supporting these accomplishments directly referenced within the letter; and
- a concise description of the impact of these accomplishments on the field.
Candidate's CV. The candidate's curriculum vitae in English, including a complete list of the candidate's publications.
Summary Statement. A statement, no more than 50 words, summarizing the candidate's research accomplishments for which he or she is being nominated.
Preferred file formats are *.doc. The candidate's CV may be submitted in a .pdf file. Your nomination is not considered fully submitted until you receive a confirmation e-mail from the AACR; confirmations will be sent within two business days.
Nominators are asked to maintain the confidentiality of the nomination process and to refrain from informing the candidate about the nomination.
There is no restriction on the number of candidates that may be nominated by any individual scientist. There is no restriction on the number of nominators that may write nomination letters or that may sign a single nomination letter on behalf of a candidate.
Nomination Instructions
Will be available in August 2010.
Selection
Candidates will be considered by a Committee of international cancer leaders appointed by the President of the AACR. After careful deliberations by the Award Committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision. Selection of the Award winner will be made on the basis of the candidate’s recent accomplishments in basic cancer research. No regard will be given to age, race, gender, nationality, geographic location, or religious or political views.
Supporter
Generously supported by Eli Lilly and Company.
Questions?
Monique P. Eversley, Program Associate
monique.eversley@aacr.org
American Association for Cancer Research
17th Floor, 615 Chestnut Street
Philadelphia, PA 19106-4404